Withdrawn × Interventional × Carcinoma, Ovarian Epithelial × Clear all Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Phase NA Withdrawn
HIPEC
Phase 2 Withdrawn
Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission
Phase 3 Withdrawn
18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
Phase 2 Withdrawn
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1 Withdrawn
Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer
Phase 1/2 Withdrawn
Toremifene in Treating Patients With Ovarian Cancer
Phase 2 Withdrawn
N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Phase 1 Withdrawn
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer
Phase NA Withdrawn
Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission
Phase 1/2 Withdrawn
FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
Phase 2 Withdrawn
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
Phase NA Withdrawn
Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
Phase 1 Withdrawn
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
Phase 2 Withdrawn
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin
Phase 2 Withdrawn
Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172
Phase NA Withdrawn
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
Phase NA Withdrawn
Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
Phase NA Withdrawn
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
Phase 1 Withdrawn
Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel
Phase 1 Withdrawn
27 enrolled